Ajosenpää, Marjo
Sarin, Satu
Vahlberg, Tero
Ahlmen-Laiho, Ulla
Yüksel, Peker
Kalleinen, Nea
Toivonen, Jenni
Funding for this research was provided by:
University of Turku
Article History
Received: 21 August 2024
Revised: 7 November 2024
Accepted: 15 November 2024
First Online: 27 November 2024
Change Date: 10 February 2025
Change Type: Update
Change Details: The original online version of this article was revised: The given and family names of authors were incorrectly structured as: Ajosenpää Marjo, Sarin Satu, Vahlberg Tero, Ahlmen-Laiho Ulla, Yüksel Peker, Kalleinen Nea, Toivonen Jenni. The correct names of authors are: Marjo Ajosenpää, Satu Sarin, Tero Vahlberg, Ulla Ahlmen-Laiho, Peker Yüksel, Nea Kalleinen, Jenni Toivonen.
Change Date: 18 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11325-025-03273-8
Declarations
: This result on this systematic review and meta-analysis indicates that OSA should be actively screened for in patients with ACS and identified OSA risk factors. Follow-up with polysomnogaphy studies after the acute phase of the coronary syndrome could also prove beneficial.
: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
: This article does not contain any studies with human participants or animals performed by any of the authors.